Brief: Quantum Genomics' Equity Stake Acquired By Orient EuroPharma
Feb 9 (Reuters) - QUANTUM GENOMICS SA ALQGC.PA :
* ORIENT EUROPHARMA ACQUIRES EQUITY STAKE IN QUANTUM
GENOMICS
* OEP SUBSCRIBED TO RESERVED CAPITAL INCREASE OF EUR
870,000, AT
PRICE OF EUR 4.83 PER SHARE
* SETTLEMENT AND DELIVERY OF NEW ORDINARY SHARES AND THEIR
ADMISSION TO TRADING ON EURONEXT GROWTH MARKET IN PARIS ARE
SCHEDULED FOR FEB 25, 2021 AT THE LATEST
Source text for Eikon: ID:nNDL80jkxY
Further company coverage: ALQGC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study